Inventor · disambiguated record
Rao V. Kalla
Also filed as: KALLA RAO · KALLA RAO V · KALLA RAO VENKATESWARA
54 granted patents·19 pending applications·574 citations·filing 1996–2024
98Inventor score
Top patents by PatentIndex Score
73 records- 0197US11939347B21′-cyano nucleoside analogs and uses thereofGILEAD SCIENCES INC·Filed 2021·Granted Mar 26, 2024·7 cites·45 claims
- 0297US11926645B2Compounds and methods for treatment of viral infectionsGILEAD SCIENCES INC·Filed 2021·Granted Mar 12, 2024·8 cites·65 claims
- 0397US11851438B21′-cyano nucleoside analogs and methods for treatment of viral infectionsGILEAD SCIENCES INC·Filed 2023·Granted Dec 26, 2023·9 cites·16 claims
- 0497US11845755B2Compounds and methods for treatment of viral infectionsGILEAD SCIENCES INC·Filed 2023·Granted Dec 19, 2023·7 cites·16 claims
- 0597US11814406B2Compounds and methods for treatment of viral infectionsGILEAD SCIENCES INC·Filed 2023·Granted Nov 14, 2023·11 cites·22 claims
- 0697US11780844B2Compounds and methods for treatment of viral infectionsGILEAD SCIENCES INC·Filed 2023·Granted Oct 10, 2023·7 cites·6 claims
- 0796US12180217B2Compounds and methods for treatment of viral infectionsGILEAD SCIENCES INC·Filed 2024·Granted Dec 31, 2024·3 cites·12 claims
- 0896US6825349B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2002·Granted Nov 30, 2004·95 cites·31 claims
- 0995US7625881B2Prodrugs of A2B adenosine receptor antagonistsGILEAD PALO ALTO INC·Filed 2006·Granted Dec 1, 2009·31 cites·17 claims
- 1095US7317017B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2005·Granted Jan 8, 2008·22 cites·15 claims
- 1194US12297226B2Compounds and methods for treatment of viral infectionsGILEAD SCIENCES INC·Filed 2024·Granted May 13, 2025·3 cites·28 claims
- 1294US9371329B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON·Filed 2014·Granted Jun 21, 2016·26 cites·2 claims
- 1394US8952034B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON·Filed 2010·Granted Feb 10, 2015·29 cites·18 claims
- 1494US8586732B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON KENNETH·Filed 2012·Granted Nov 19, 2013·29 cites·35 claims
- 1594US6977300B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2003·Granted Dec 20, 2005·69 cites·25 claims
- 1693US11897878B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2021·Granted Feb 13, 2024·2 cites·65 claims
- 1793US7741331B2A2B adenosine receptor antagonistsGILEAD PALO ALTO INC·Filed 2007·Granted Jun 22, 2010·16 cites·8 claims
- 1892US11925631B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2021·Granted Mar 12, 2024·2 cites·37 claims
- 1991US9676760B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 13, 2017·7 cites·2 claims
- 2091US9598435B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2015·Granted Mar 21, 2017·9 cites·13 claims
- 2191US7125993B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2003·Granted Oct 24, 2006·37 cites·47 claims
- 2290US9193694B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2013·Granted Nov 24, 2015·11 cites·11 claims
- 2390US7795269B2A2B adenosine receptor antagonistsGILEAD PALO ALTO INC·Filed 2007·Granted Sep 14, 2010·8 cites·14 claims
- 2490US2025197410A1Compounds and methods for treatment of viral infectionsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2589US12448383B2Compounds and methods for treatment of viral infectionsGILEAD SCIENCES INC·Filed 2023·Granted Oct 21, 2025·0 cites·10 claims
- 2689US11453681B2Substituted eneoxindoles and uses thereofGILEAD SCIENCES INC·Filed 2020·Granted Sep 27, 2022·2 cites·53 claims
- 2789US11071730B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2019·Granted Jul 27, 2021·4 cites·40 claims
- 2889US8389500B2Fused heterocyclic compounds as ion channel modulatorsABELMAN MATTHEW·Filed 2009·Granted Mar 5, 2013·16 cites·24 claims
- 2988US11203591B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2019·Granted Dec 21, 2021·6 cites·45 claims
- 3087US7521554B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2006·Granted Apr 21, 2009·7 cites·5 claims
- 3186US7304070B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2004·Granted Dec 4, 2007·23 cites·36 claims
- 3284US9403782B2Fused heterocyclic compounds as ion channel modulatorsGILEAD SCIENCES INC·Filed 2015·Granted Aug 2, 2016·4 cites·10 claims
- 3384US8324224B2A2B adenosine receptor antagonistsKALLA RAO·Filed 2011·Granted Dec 4, 2012·5 cites·8 claims
- 3484US2023295172A1Compounds and methods for treatment of viral infectionsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 3583US8158810B2ALDH-2 inhibitors in the treatment of addictionZABLOCKI JEFF·Filed 2009·Granted Apr 17, 2012·7 cites·11 claims
- 3682US11040033B2Therapeutic heterocyclic compoundsGILEAD SCIENCES INC·Filed 2018·Granted Jun 22, 2021·1 cites·22 claims
- 3782US8962610B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON KENNETH·Filed 2012·Granted Feb 24, 2015·6 cites·21 claims
- 3881US12404289B21′-cyano nucleoside analogs and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Sep 2, 2025·0 cites·11 claims
- 3981US9115096B2Fused heterocyclic compounds as ion channel modulatorsCORKEY BRITTON KENNETH·Filed 2012·Granted Aug 25, 2015·5 cites·13 claims
- 4081US7381714B2A1 adenosine receptor agonistsCV THERAPEUTICS INC·Filed 2006·Granted Jun 3, 2008·4 cites·22 claims
- 4180US8143249B2Prodrugs of A2B adenosine receptor antagonistsKALLA RAO·Filed 2011·Granted Mar 27, 2012·4 cites·10 claims
- 4280US7105665B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2004·Granted Sep 12, 2006·12 cites·33 claims
- 4378US12258346B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2023·Granted Mar 25, 2025·0 cites·23 claims
- 4477US7514417B2A1 adenosine receptor agonistsCV THERAPEUTICS INC·Filed 2006·Granted Apr 7, 2009·2 cites·23 claims
- 4572US7449473B2Substituted pyrrolo[3,2-d]pyrimidin-2,4-diones as A2b adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2004·Granted Nov 11, 2008·5 cites·16 claims
- 4671US12116380B2Phospholipid compounds and methods of making and using the sameGILEAD SCIENCES INC·Filed 2022·Granted Oct 15, 2024·0 cites·18 claims
- 4770US12037342B2Substituted eneoxindoles and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Jul 16, 2024·0 cites·54 claims
- 4870US2025034182A1Phospholipid compounds and methods of making and using the sameGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 4966US2025084088A1Antiviral compounds and methods of making and using the sameGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 5066US2023322813A1Compounds and methods for treatment of viral infectionsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
Showing the top 50 of 73 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →